4//SEC Filing
Gilmore Geoffrey 4
Accession 0001104659-23-077174
CIK 0001261249other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:36 PM ET
Size
9.4 KB
Accession
0001104659-23-077174
Insider Transaction Report
Form 4
Gilmore Geoffrey
General Counsel
Transactions
- Award
Common Stock
2023-06-28+6,716→ 20,256 total - Award
Employee Stock Option (Right to Buy)
2023-06-28+4,500→ 4,500 totalExercise: $2.48Exp: 2033-06-27→ Common Stock (4,500 underlying) - Award
Common Stock
2023-06-28+13,500→ 13,540 total
Footnotes (4)
- [F1]These shares represent restricted stock units ("RSUs") which were granted on June 28, 2023. The RSUs will vest in four equal installments over four years upon the anniversary of the grant, such that the RSUs will be fully vested on June 28, 2027.
- [F2]On April 10, 2023, the Issuer completed a one-for-fifty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split.
- [F3]These shares represent RSUs that were granted on June 28, 2023, which will vest and be settled in common stock on June 28, 2024.
- [F4]This option was granted on June 28, 2023. 25% of the shares subject to the stock option vest on June 28, 2024, and the remaining shares vest in 36 substantially equal monthly installments over the following three years such that the option will be fully vested on June 28, 2027.
Documents
Issuer
AGILE THERAPEUTICS INC
CIK 0001261249
Entity typeother
Related Parties
1- filerCIK 0001429407
Filing Metadata
- Form type
- 4
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:36 PM ET
- Size
- 9.4 KB